Clinical experience with two new methanesulfonic acid esters of aminoglycols, NSC-140115 and NSC-140117, in the treatment of malignant lymphoma.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001190:Arylsulfonates / Q000627:therapeutic use; D001772:Blood Cell Count; D002648:Child; D002986:Clinical Trials as Topic; D004952:Esters; D005260:Female; D006018:Glycols / Q000627:therapeutic use*; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D008099:Liver / Q000473:pathology; D008223:Lymphoma / Q000097:blood / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008698:Mesylates / Q000627:therapeutic use*; D008875:Middle Aged; D013154:Spleen / Q000473:pathology; D013921:Thrombocytopenia / Q000150:complications
D001190:Arylsulfonates; D004952:Esters; D006018:Glycols; D006454:Hemoglobins; D008698:Mesylates